Published in Cancer Weekly, November 11th, 2003
In a news release and conference call with analysts, Cell Therapeutics, Inc., (CTI) officials said fewer than 10 patients had died after their infection-fighting white blood cells were destroyed in the tests. Company officials would not give the exact number of deaths.
The patients who died had a median life expectancy of 10 weeks; the company did not say at what point in their treatment they died. It also would not say how many more patients died while being administered the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.